Parametric Portfolio Associates’s Rapid Micro Biosystems RPID Stock Holding History

Parametric Portfolio Associates’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$117K	Buy	+17,158	New	+$126K	﹤0.01%	3541

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

Parametric Portfolio Associates's RPID Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Rapid Micro Biosystems (RPID) in Q1 2022: 17,158 shares worth $117K. The stake represents ﹤0.01% of the portfolio and ranks #3541 among its holdings.

59 funds tracked by Wall St. Rank hold RPID as of Q1 2022.

Parametric Portfolio Associates held 17,158 shares of Rapid Micro Biosystems worth $117K as of Q1 2022.
Rapid Micro Biosystems was a new Parametric Portfolio Associates position in Q1 2022.
Rapid Micro Biosystems made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3541 holding.
59 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.